Camurus announces approval of Oczyesa (octreotide SC) for the treatment of acromegaly in the UK
Camurus announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Oczyesa, (octreotide subcutaneous depot), marketing authorization for the maintenance treatment in adult patients with… read more.
